Veru Reports Fiscal 2026 Third Quarter Financial Results and Phase 2b PLATEAU Clinical Trial Progress
Enrollment • Phase 2Enrollment milestone Mon, Aug 10, 2026, 6:30 AM EDT
Company profile
Veru Inc.
Pipeline2 assets
- EnobosarmVERU-024 / GTx-024 / Ostarine
- SabizabulinVERU-111
Latest news9 items
All newsVeru Announces Full Enrollment for Phase 2b PLATEAU Clinical Trial of Enobosarm and Semaglutide Combination for High Quality Weight Loss
Enrollment • Phase 2oral presentation Mon, Jul 27, 2026
Veru Reports Fiscal 2026 Second Quarter Financial Results and Phase 2b PLATEAU Clinical Trial Progress
Interim Data • Phase 2Interim analysis Wed, Mar 31, 2027, 6:30 AM EDT